At the IGTP TODAY
The combination of the drug nivolumab with chemotherapy improves survival in patients with high-risk head and neck cancer and could become the new standard treatment, according to the results of an international trial led by professionals from ICO, IGTP and IDIBELL.
A study coordinated from Badalona by IrsiCaixa, the Catalan Institute of Oncology and the Germans Trias i Pujol Research Institute (within the CARE programme) has identified KIMA, a genomic signature that makes it possible to anticipate which patients with HR+/HER2- breast cancer will respond less well to CDK4/6 inhibitors. The finding, published in the journal Clinical and Translational Medicine, may help personalize therapies and design new combinations.
The "la Caixa" Foundation has announced the results of the 2025 call for proposals for its CaixaImpulse program, through which it supports 31 biomedical projects from research centres, hospitals and universities in Spain and Portugal. A project coordinated by IIS IGTP led by Ana Piqueras (HUGTiP) has been selected in the call to continue with the development and implementation of a medical device to find and remove cancer cells more accurately during surgery.
On 18 September, around thirty people involved in the Innomed program visited the Werfen facilities in Lliçà d'Amunt (the Immunoassay Technology Center). The meeting provided an opportunity to learn about the company's strategic areas and to establish contacts for exploring possible collaborations.
The report, available in its extended format and in summary versions, compiles the institution's activity during 2024 and reflects its growth and consolidation.
The iCor team at the Germans Trias i Pujol University Hospital and Research Institute is the first in Spain to enrol a patient in the international EASY-AS study, a clinical trial to evaluate whether intervening before the first symptoms of severe aortic stenosis appear can improve clinical outcomes.
The Germans Trias i Pujol University Hospital and Research Institute welcomed patients and families from several European countries as part of the NF Academy 2025, an event organised by Neurofibromatosis Patients United together with the ACNEFI to train and empower young people living with NF1, NF2-SWN and SWN.
On the occasion of World Hepatitis Day, IGTP presents the results of the HepBClink project, which has combined community educational actions on hepatitis B and C with screening and referral to treatment for migrants from Pakistan, Senegal and Romania. The project has involved the participation of the DxEpiPath group at IGTP and is part of the Tranversal Program CORE.
A team of researchers from the IGTP has taken a step forward in understanding the complex structure of heart scars that form after a myocardial infarction. Using a porcine model, the group found an association between specific electrical patterns and structural characteristics of the scar, offering a new approach that may guide more targeted and effective treatments for arrhythmias. The results have been published in the journal Heart Rhythm.
Researchers at IGTP, HUGTiP and ICO Badalona have identified genetic alterations, including frequent TP53 mutations, that could serve as biomarkers to guide treatment decisions in HER2-positive breast cancer.
